Gujarat Terce Laboratories Ltd

GUJTERC

Watchlist

AI Mode

‌

Market Cap

₹ 32 Cr

P/E

—

Turned 1 L into 5.76 L in last 5 Years

‌

Investment Checklist

How to read checklist?

Performance

MARKET LEADER

Valuation

REASONABLE

Growth

STABLE

Profitability

LOW MARGIN

Technicals

Bearish

Risk

MODERATE RISK

Investment Checklist

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

‌
‌

‌

Price

PE Ratio

Price

‌

Overview

Detailed Summary

Gujarat Terce Laboratories Limited is a pharmaceutical company focused on producing branded generic formulations for the domestic market.

The company maintains an ISO 9001 certified and WHO-GMP compliant facility, with an annual capacity of 270 million tablets and 108 million capsules.

Despite a slight revenue contraction in Q2 FY26, EBITDA performance reached a historical high, driven by disciplined cost control and operational optimization.

Gujarat Terce completed three quarters without external funding, showcasing its operational efficiency and financial resilience through self-sustained growth.

With a footprint across 13 states in India and a strong portfolio in high-growth therapeutic areas, the company targets sustainable growth and long-term stakeholder value.

Sector

Pharmaceuticals

Industry

Pharmaceuticals - Indian - Formulations

Market Cap

32 Cr

Volatility

Low Risk

P/E Ratio

—

Industry P/E

43.8

PEG Ratio

—

P/B Ratio

4.3

52W High

92.22

52W Low

37.20

Sales CAGR

4.65%

7.74%

5.98%

10Y

8.05%

Profit CAGR

-508.33%

—

10Y

—

ROE

TTM

-13.06%

-11.77%

-11.07%

10Y

-4.21%

ROCE

TTM

39.56%

8.59%

3.23%

10Y

3.22%

Technicals

‌

Forecasts

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
SANDUPHQ	39.30	38 Cr	24.34	1.13	2.04	3.69	5.32	2.80
JFLLIFE	11.25	37 Cr	10.51	0.88	0.00	8.41	12.26	4.11
NIYATILEAS	18.47	37 Cr	80.35	1.63	0.00	2.04	2.92	1.35
GUJTERC	43.49	32 Cr	—	4.30	0.00	-13.06	39.56	-4.18
MEDIORG	25.10	29 Cr	7.25	1.00	0.00	14.02	13.68	7.49
PANJON	16.59	28 Cr	38.58	1.68	0.00	4.40	4.69	3.44
COLINZ	49.00	22 Cr	48.65	1.88	0.00	4.69	5.88	3.79

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

AI Mode

Consolidated Quarterly Results (in ₹ Crores)

View Standalone

Total Figures

QoQ Changes

Total Figures

	Dec 2018	Sep 2019	Dec 2019	Jun 2020	Sep 2020	Jun 2021	Sep 2021
Sales	8.31	11	10	4.98	7.20	9.94	10
Expenses	7.64	9.31	9.66	5.38	7.09	8.31	9.59
Operating Profit	0.67	1.84	0.45	-0.40	0.11	1.63	0.54
OPM %	8.06	16.50	4.45	-8.03	1.53	16.40	5.33
Other Income	0.00	0.01	0.01	0.07	0.09	0.07	0.08
Interest	0.05	0.10	0.04	0.05	0.17	0.05	0.10
Depreciation	0.05	0.06	0.06	0.06	0.04	0.05	0.05
Profit Before Tax	0.57	1.69	0.37	-0.44	-0.02	1.60	0.45
Tax %	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit	0.57	1.69	0.37	-0.44	-0.02	1.60	0.45
EPS in Rs	0.77	2.28	0.50	-0.60	-0.02	2.16	0.61

Standalone Profit Loss (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	25	29	31	38	25	40	47	48	50	49
Expenses	25	29	31	37	28	39	49	47	46	45
Operating Profit	0.08	0.32	0.49	0.68	-2.77	1.12	-2.16	1.27	3.88	3.78
OPM %	0.32	1.11	1.57	1.82	-10.99	2.78	-4.62	2.64	7.74	7.69
Other Income	0.44	0.41	0.32	0.29	0.80	0.31	0.35	0.32	0.31	0.33
Interest	0.31	0.23	0.25	0.29	0.39	0.40	0.72	0.68	0.42	0.33
Depreciation	0.19	0.19	0.21	0.24	0.18	0.28	0.36	0.37	0.38	0.39
Profit Before Tax	0.02	0.33	0.35	0.44	-2.53	0.75	-2.89	0.54	3.39	3.39
Tax %	168.67	16.75	-25.10	36.64	0.45	-16.84	42.24	55.25	128.87	127.73
Net Profit	-0.01	0.27	0.43	0.28	-2.52	0.87	-1.67	0.24	-0.98	-0.94
EPS in Rs	-0.41	0.26	0.46	0.37	-3.40	-0.77	-2.25	0.33	-1.09	-1.25
Dividend Payout %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—

Standalone Balance Sheet (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	7.42	7.42	7.42	7.42	7.42	7.42	7.42	7.42	7.42	7.42
Reserves	2.94	2.64	2.98	3.41	3.69	0.24	1.11	-0.56	-0.31	-0.94
Borrowings	7.12	6.99	0.34	0.65	2.53	4.74	6.67	7.27	3.87	0.94
Other Liabilities	6.99	6.61	8.72	7.85	8.86	9.47	12	14	12	15
Total Liabilities	24	24	19	19	23	22	27	29	23	23
Fixed Assets	6.34	6.17	1.88	2.06	2.29	2.45	4.29	3.99	3.69	3.65
CWIP	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.30	0.24	0.27	0.29	0.27	0.27	0.27	0.27	0.27	0.52
Other Assets	18	17	17	17	20	19	23	24	19	19
Total Assets	24	24	19	19	23	22	27	29	23	23

Standalone Cash Flows (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	0.16	0.24	4.58	-0.61	-1.59	-0.16	-0.44	0.03	2.60	3.06
Cash from Investing Activity	-0.13	0.18	1.11	-0.13	-0.27	-0.42	-0.87	0.62	-0.46	0.46
Cash from Financing Activity	-1.43	-0.36	-5.39	0.20	1.72	1.83	1.53	-0.12	-4.08	-2.83
Net Cash Flow	-1.39	0.06	0.29	-0.55	-0.14	1.24	0.22	0.52	-1.94	0.69

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Promoters	36.22%	36.45%	36.65%	36.78%	37.01%	37.03%	37.03%	37.03%	37.03%	37.03%	37.03%	37.03%
FIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
DIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Public	63.78%	63.55%	63.35%	63.22%	62.99%	62.97%	62.97%	62.97%	62.97%	62.97%	62.97%	62.97%
Total Shareholders	13,625	13,579	13,499	13,404	13,327	13,203	13,394	13,538	13,710	13,764	13,804	13,812

Market Transactions

Date	Party	Category	Type	Avg Price (₹)	Total Value (₹)	Quantity	Percent Traded
Jun 26, 2025	Nelvin george	Bulk	Sell	51.37	0.21 Cr	40,212	0.54
Nov 06, 2024	Aalap natwarbhai prajapati	Insider - Promoter	Acquisition	—	—	9,27,150	12.4
Nov 06, 2024	Manjulaben s. prajapati	Insider - Promoter	Disposal	—	—	9,27,150	12.49
Apr 15, 2024	Mable rajesh	Bulk	Buy	52.40	0.38 Cr	73,000	0.98
Feb 17, 2024	Natwarbhai prajapati	Insider - Promoter & Director	Acquisition	28.00	0.03 Cr	12,055	0.16
Nov 28, 2023	Natwarbhai prajapati	Insider - Promoter & Director	Acquisition	26.42	0.01 Cr	4,502	0.06
Nov 17, 2023	Natwarbhai prajapati	Insider - Promoter & Director	Acquisition	23.00	0.00 Cr	998	0.01
Nov 17, 2023	Dhanpat m kothari	Bulk	Buy	24.92	0.11 Cr	44,772	0.60
Sep 29, 2023	Natwarbhai prajapati	Insider - Promoter & Director	Acquisition	23.89	0.01 Cr	3,000	0.04
Sep 29, 2023	Aalap prajapati	Insider - Promoter & Director	Acquisition	26.02	0.01 Cr	5,750	0.07

Projection

Actions

Action Type

‌
‌

Announcements

Last 7 days

Newest

Sentiment

Equity Share Allotment

1 hour ago

Equity Shares Allotment to Promoter

The Board of Directors has approved the conversion of 371,000 fully convertible warrants into the same number of equity shares at an issue price of ₹37.70 each.

Documents

Presentations

Concalls

Reports

Presentations

Investor Presentation

Q2 FY26

Investor Presentation

Q1 FY26

Investor Presentation

Q4 FY25

Investor Presentation

Q3 FY25

Investor Presentation

Q3 FY25

Investor Presentation

Q2 FY25

Investor Presentation

Q1 FY25

Investor Presentation

Q4 FY24

Showing 1 - 8 of 16

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.

AI Mode

Financial Statements

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

AI Mode

Consolidated Quarterly Results (in ₹ Crores)

View Standalone

Total Figures

QoQ Changes

Total Figures

	Dec 2018	Sep 2019	Dec 2019	Jun 2020	Sep 2020	Jun 2021	Sep 2021
Sales	8.31	11	10	4.98	7.20	9.94	10
Expenses	7.64	9.31	9.66	5.38	7.09	8.31	9.59
Operating Profit	0.67	1.84	0.45	-0.40	0.11	1.63	0.54
OPM %	8.06	16.50	4.45	-8.03	1.53	16.40	5.33
Other Income	0.00	0.01	0.01	0.07	0.09	0.07	0.08
Interest	0.05	0.10	0.04	0.05	0.17	0.05	0.10
Depreciation	0.05	0.06	0.06	0.06	0.04	0.05	0.05
Profit Before Tax	0.57	1.69	0.37	-0.44	-0.02	1.60	0.45
Tax %	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit	0.57	1.69	0.37	-0.44	-0.02	1.60	0.45
EPS in Rs	0.77	2.28	0.50	-0.60	-0.02	2.16	0.61

Standalone Profit Loss (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	25	29	31	38	25	40	47	48	50	49
Expenses	25	29	31	37	28	39	49	47	46	45
Operating Profit	0.08	0.32	0.49	0.68	-2.77	1.12	-2.16	1.27	3.88	3.78
OPM %	0.32	1.11	1.57	1.82	-10.99	2.78	-4.62	2.64	7.74	7.69
Other Income	0.44	0.41	0.32	0.29	0.80	0.31	0.35	0.32	0.31	0.33
Interest	0.31	0.23	0.25	0.29	0.39	0.40	0.72	0.68	0.42	0.33
Depreciation	0.19	0.19	0.21	0.24	0.18	0.28	0.36	0.37	0.38	0.39
Profit Before Tax	0.02	0.33	0.35	0.44	-2.53	0.75	-2.89	0.54	3.39	3.39
Tax %	168.67	16.75	-25.10	36.64	0.45	-16.84	42.24	55.25	128.87	127.73
Net Profit	-0.01	0.27	0.43	0.28	-2.52	0.87	-1.67	0.24	-0.98	-0.94
EPS in Rs	-0.41	0.26	0.46	0.37	-3.40	-0.77	-2.25	0.33	-1.09	-1.25
Dividend Payout %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—

Standalone Balance Sheet (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	7.42	7.42	7.42	7.42	7.42	7.42	7.42	7.42	7.42	7.42
Reserves	2.94	2.64	2.98	3.41	3.69	0.24	1.11	-0.56	-0.31	-0.94
Borrowings	7.12	6.99	0.34	0.65	2.53	4.74	6.67	7.27	3.87	0.94
Other Liabilities	6.99	6.61	8.72	7.85	8.86	9.47	12	14	12	15
Total Liabilities	24	24	19	19	23	22	27	29	23	23
Fixed Assets	6.34	6.17	1.88	2.06	2.29	2.45	4.29	3.99	3.69	3.65
CWIP	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.30	0.24	0.27	0.29	0.27	0.27	0.27	0.27	0.27	0.52
Other Assets	18	17	17	17	20	19	23	24	19	19
Total Assets	24	24	19	19	23	22	27	29	23	23

Standalone Cash Flows (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	0.16	0.24	4.58	-0.61	-1.59	-0.16	-0.44	0.03	2.60	3.06
Cash from Investing Activity	-0.13	0.18	1.11	-0.13	-0.27	-0.42	-0.87	0.62	-0.46	0.46
Cash from Financing Activity	-1.43	-0.36	-5.39	0.20	1.72	1.83	1.53	-0.12	-4.08	-2.83
Net Cash Flow	-1.39	0.06	0.29	-0.55	-0.14	1.24	0.22	0.52	-1.94	0.69

Peers

Symbol	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
SANDUPHQ	39.30	38 Cr	24.34	1.13	2.04	3.69	5.32	2.80
JFLLIFE	11.25	37 Cr	10.51	0.88	0.00	8.41	12.26	4.11
NIYATILEAS	18.47	37 Cr	80.35	1.63	0.00	2.04	2.92	1.35
GUJTERC	43.49	32 Cr	—	4.30	0.00	-13.06	39.56	-4.18
MEDIORG	25.10	29 Cr	7.25	1.00	0.00	14.02	13.68	7.49
PANJON	16.59	28 Cr	38.58	1.68	0.00	4.40	4.69	3.44
COLINZ	49.00	22 Cr	48.65	1.88	0.00	4.69	5.88	3.79

Gujarat Terce completed three quarters without external funding, showcasing its operational efficiency and financial resilience through self-sustained growth.

With a footprint across 13 states in India and a strong portfolio in high-growth therapeutic areas, the company targets sustainable growth and long-term stakeholder value.

Sector

Pharmaceuticals

Industry

Pharmaceuticals - Indian - Formulations

Market Cap

32 Cr

Volatility

Low Risk

P/E Ratio

—

Industry P/E

43.8

PEG Ratio

—

P/B Ratio

4.3

52W High

92.22

52W Low

37.20

Sales CAGR

4.65%

7.74%

5.98%

10Y

8.05%

Profit CAGR

-508.33%

—

10Y

—

ROE

TTM

-13.06%

-11.77%

-11.07%

10Y

-4.21%

ROCE

TTM

39.56%

8.59%

3.23%

10Y

3.22%